Specifically, the mean tumor length was 21.07 ± 8.99 mm in HER2 positive cases, 14.25 ± 7.36 mm in borderline cases, and 21.04 ± 9.57 mm in HER2 negative cases (p‐value = 0.163). This evidence concerns the gene ERBB2 and neoplasm.